Loading clinical trials...
Loading clinical trials...
The increasing incidence of Esophageal Adenocarcinoma (EAC) in several Western countries can be primarily ascribed to risk factors such as obesity, chronic gastroesophageal reflux, dietary habits and ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istituto Oncologico Veneto IRCCS
NCT04805502 · Pregnancy, Overweight and Obesity
NCT05745857 · Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, and more
NCT06555393 · High Blood Sugar, High Blood Pressure, and more
NCT06526273 · Type 2 Diabetes, Hypertension, and more
NCT06523374 · Barrett's Esophagus, Esophageal Adenocarcinoma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions